-
Mashup Score: 0
A little-known data firm helps health insurers make more when less of an out-of-network claim gets paid. Patients can be on the hook for the difference.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 143Knuckleheads - 25 day(s) ago
Partnering with patients who reject our recommended treatment: how to understand what our patients are going through
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Yay: my latest Art of Oncology essay is now published. It discusses working effectively with patients who decline our treatment recommendations. @JCO_ASCO @ASCO @ClevelandClinic @CleClinicMD @CleClinicLCM Knuckleheads | Journal of Clinical Oncology https://t.co/HNQSoudcUC
-
-
Mashup Score: 126Knuckleheads - 29 day(s) ago
Partnering with patients who reject our recommended treatment: how to understand what our patients are going through
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Yay: my latest Art of Oncology essay is now published. It discusses working effectively with patients who decline our treatment recommendations. @JCO_ASCO @ASCO @ClevelandClinic @CleClinicMD @CleClinicLCM Knuckleheads | Journal of Clinical Oncology https://t.co/HNQSoudcUC
-
-
Mashup Score: 124Knuckleheads - 1 month(s) ago
Partnering with patients who reject our recommended treatment: how to understand what our patients are going through
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Yay: my latest Art of Oncology essay is now published. It discusses working effectively with patients who decline our treatment recommendations. @JCO_ASCO @ASCO @ClevelandClinic @CleClinicMD @CleClinicLCM Knuckleheads | Journal of Clinical Oncology https://t.co/HNQSoudcUC
-
-
Mashup Score: 110Knuckleheads - 1 month(s) ago
Partnering with patients who reject our recommended treatment: how to understand what our patients are going through
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Yay: my latest Art of Oncology essay is now published. It discusses working effectively with patients who decline our treatment recommendations. @JCO_ASCO @ASCO @ClevelandClinic @CleClinicMD @CleClinicLCM Knuckleheads | Journal of Clinical Oncology https://t.co/HNQSoudcUC
-
-
Mashup Score: 48Cancer Stories: The Art of Oncology: Knuckleheads: Understanding Patients Who Reject Treatment - 1 month(s) ago
Listen to ASCO’s Journal of Clinical Oncology essay, “Knuckleheads” by Dr. Timothy Gilligan, Vice Chair for Education at the Cleveland Clinic Taussig Cancer Institute. The essay is followed by an interview with Gilligan and host Dr. Lidia Schapira. Gilligan emphasizes the importance of partnering with his patients to understand what they are going through and their reason for rejecting recommended treatment. TRANSCRIPT Narrator: Knuckleheads by Tmothy D. Gilligan, MD, FASCO () I was in tumor board when I first heard about him. One of my former colleagues referred to patients like this as knuckleheads, patients who were interfering with our plan to treat their cancer. He needed chemotherapy. He kept refusing. He was going to be referred to me so that I could talk some sense into him. Preparing to go into the examination room, I realized I was getting ready to use my medical knowledge to try to make him consent to chemotherapy. After all, that is what he needed. If only he would listen
Source: sites.libsyn.comCategories: General Medicine News, Hem/OncsTweet-
Very excited that the podcast and interview about my latest JCO Art of Oncology essay has been released! Please check it out. @JCO_ASCO @ASCO @ClevelandClinic @CleClinicMD @CleClinicLCM https://t.co/GbRymPRWDx
-
-
Mashup Score: 4Follow @JCO_ASCO on Twitter - 7 month(s) ago
Explore Art of Oncology’s rich collection of poignant essays and heartfelt poems sharing insights, emotions, and reflections on the human side of cancer medicine.
Source: ascopubs.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Honored to be included in this collection of essays by writers whom I admire and from whom I have learned so much. #CleClinicCancer @CleClinicMD Art of Oncology Special Edition | Journal of Clinical Oncology https://t.co/iDQWtkxEJh
-
-
Mashup Score: 1
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @MikkaelSekeres: Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations - The New York Times https://t.co/axdjwVsAeH
-
-
Mashup Score: 3Who Employs Your Doctor? Increasingly, a Private Equity Firm. - 10 month(s) ago
A new study finds that private equity firms own more than half of all specialists in certain U.S. markets.
Source: www.nytimes.comCategories: Latest Headlines, Oncologists1Tweet-
RT @n8pennell: Who Employs Your Doctor? Increasingly, a Private Equity Firm. https://t.co/sZVdL3eXle
-
-
Mashup Score: 0Affirmative Action: Supreme Court Strikes Down Race-Based Admissions at Harvard and U.N.C. - 10 month(s) ago
The 6-3 ruling could drastically alter college admissions policies across the country. Criticizing the decision, President Biden said this was “not a normal court” and directed the Education Department “to analyze what practices can build a more inclusive and diverse” student body.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
“The Supreme Court’s ruling is expected to lower the number of Black and Latino students at medical schools, law schools and other professional degree programs.” #StructuralRacism https://t.co/vEyBEOMcFx
-
Insurers Reap Hidden Fees by Slashing Payments. You May Get the Bill. https://t.co/j9JSZpWzLd